By: Eric Sagonowsky
Following reports of an ex-AstraZeneca executive being detained in China, the company acknowledged that its current president in the country, Leon Wang, "is cooperating with an ongoing investigation."
Eric Sagonowsky is a Senior Editor at Fierce Life Sciences. He covers a range of topics within medicine and healthcare, alternative medicine, and business economics, with a particular focus on the FDA, Coronavirus, and leading biotech companies like Moderna and AstraZeneca. Eric's insights and analyses have been featured in Biotech and Fierce Pharma.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Eric Sagonowsky's articles predominantly cover announcements from the healthcare and pharmaceutical sectors, with a focus on FDA approvals, drug companies, medical research, and broader healthcare topics. His coverage suggests he would likely be interested in receiving pitches related to new drug approvals, clinical trial results or significant developments within pharmaceutical companies.
Given his extensive press release coverage (28%), Eric is likely open to receiving news directly from pharmaceutical companies about their latest products and milestones. Additionally, given the emphasis on government announcements (16%), he might also be interested in regulatory changes impacting the industry.
Since there is no specified geographic focus for Eric's coverage area, it can be inferred that he covers global developments within the pharmaceutical and healthcare industries.
This information evolves through artificial intelligence and human feedback. Improve this profile .